Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
International Immunopharmacology
|
January 30, 2026
Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies
Shubham Upadhayay
Molecular Neurobiology
|
March 23, 2026
Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches
Shubham Upadhayay
Pharmacological Reports : PR
|
July 9, 2024
Mitochondrial targeted antioxidants as potential therapy for huntington's disease
Shubham Upadhayay, Puneet Kumar
Neurochemical Research
|
June 2, 2021
Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS
Elizabeth Minj, Shubham Upadhayay, Sidharth Mehan
Neurotoxicity Research
|
August 25, 2021
Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases
Anshuman Singh, Shubham Upadhayay, Sidharth Mehan
Inflammopharmacology
|
June 12, 2026
Reprogramming immunity: the promise and challenges of CAR T cell therapy in multiple sclerosis
Nitik Kumawat, Aarti Sharma, Shubham Upadhayay
European Journal of Cell Biology
|
September 24, 2021
Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctions
Rakesh Sahu, Shubham Upadhayay, Sidharth Mehan
Journal of Biochemical and Molecular Toxicology
|
July 28, 2025
Raloxifene and Fulvestrant Exert Antioxidant, Anti-Inflammatory, and Antiapoptotic Action Against Haloperidol-Induced Tardive Dyskinesia in Rats via Activation of the GPER1/PI3k/Akt/Nrf2/HO-1 Signaling Pathways
Shubham Upadhayay, Divya Soni, Puneet Kumar
Expert Opinion on Drug Discovery
|
April 12, 2023
Animal models of Huntington's disease and their applicability to novel drug discovery and development
Shubham Upadhayay, Sumit Jamwal, Puneet Kumar
Neurochemical Research
|
March 15, 2025
G-Protein-Coupled Estrogen Receptor 1 (GPER1) Activation Mitigates Haloperidol-Induced Neurotoxicity in SHSY-5Y Cells and Improves Motor Functions in Adult Zebrafish
Shubham Upadhayay, Vivek Uttam, Puneet Kumar
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
International Immunopharmacology
|
January 30, 2026
Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies
Shubham Upadhayay
Molecular Neurobiology
|
March 23, 2026
Role of Pentacyclic Triterpenes in the Management of Neurological Disorders: An Insight into Molecular Mechanisms and Therapeutic Approaches
Shubham Upadhayay
Pharmacological Reports : PR
|
July 9, 2024
Mitochondrial targeted antioxidants as potential therapy for huntington's disease
Shubham Upadhayay, Puneet Kumar
Neurochemical Research
|
June 2, 2021
Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS
Elizabeth Minj, Shubham Upadhayay, Sidharth Mehan
Neurotoxicity Research
|
August 25, 2021
Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases
Anshuman Singh, Shubham Upadhayay, Sidharth Mehan
Inflammopharmacology
|
June 12, 2026
Reprogramming immunity: the promise and challenges of CAR T cell therapy in multiple sclerosis
Nitik Kumawat, Aarti Sharma, Shubham Upadhayay
European Journal of Cell Biology
|
September 24, 2021
Inhibition of extracellular regulated kinase (ERK)-1/2 signaling pathway in the prevention of ALS: Target inhibitors and influences on neurological dysfunctions
Rakesh Sahu, Shubham Upadhayay, Sidharth Mehan
Journal of Biochemical and Molecular Toxicology
|
July 28, 2025
Raloxifene and Fulvestrant Exert Antioxidant, Anti-Inflammatory, and Antiapoptotic Action Against Haloperidol-Induced Tardive Dyskinesia in Rats via Activation of the GPER1/PI3k/Akt/Nrf2/HO-1 Signaling Pathways
Shubham Upadhayay, Divya Soni, Puneet Kumar
Expert Opinion on Drug Discovery
|
April 12, 2023
Animal models of Huntington's disease and their applicability to novel drug discovery and development
Shubham Upadhayay, Sumit Jamwal, Puneet Kumar
Neurochemical Research
|
March 15, 2025
G-Protein-Coupled Estrogen Receptor 1 (GPER1) Activation Mitigates Haloperidol-Induced Neurotoxicity in SHSY-5Y Cells and Improves Motor Functions in Adult Zebrafish
Shubham Upadhayay, Vivek Uttam, Puneet Kumar
Page
of 3